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Abstract Lining the inner surface of the circulatory system,
the vascular endothelium accomplishes a vast variety of spe-
cialized functions. Even slight alterations of these functions
are implicated in the development of certain cardiovascular
diseases that represent major causes of morbidity and mortal-
ity in developed countries. Endothelial mitochondria are
essential to the functional integrity of the endothelial cell as
they integrate a wide range of cellular processes including Ca2+
handling, redox signaling and apoptosis, all of which are
closely interrelated. Growing evidence supports the notion that
impairment ofmitochondrial signaling in the endothelium is an
early event and a causative factor in the development of dis-
eases such as atherosclerosis or diabetic complications. In this
review, we want to outline the significance of mitochondria in
both physiology and pathology of the vascular endothelium.
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Introduction
As the blood vessel’s innermost layer, the vascular endothe-
lium fulfills a great multitude of regulatory and sensory
functions [23]. Impairment of any of these functions leads
to distinct entities of cardiovascular diseases that collectively
represent one of the major causes of overall morbidity and
mortality in developed countries [103]. The functional intact-
ness of the vascular endothelium is, therefore, of vital impor-
tance. The capability of mitochondria to dramatically interfere
with endothelial function has just recently started to draw
attention to this organelle.
The primary role of mitochondria is to produce and regu-
late the production of energy-rich molecules such as adeno-
sine triphosphate (ATP), via aerobic respiration. At first
impression, these cellular power plants might not seem to be
of particular importance to the endothelial cell, a type of cell
that usually covers over two-thirds of its energy demands by
anaerobic glycolysis [32, 33, 118], but at a second glance,
mitochondria turn out to be essential to endothelial function in
many ways and are far more than just a source of ATP.
Mitochondria constitute multifunctional organelles that are
able to specifically regulate the signaling of cellular messen-
gers such as Ca2+ and reactive oxygen species (ROS) within
cells. In addition, mitochondria have been recognized to deter-
mine the fate of cells by controlling apoptosis, the process of
programmed cell death. In this review, we intend to take a
closer look at these specific functions and possible dysfunc-
tions of mitochondria in the vascular endothelium.
Mitochondrial contribution to endothelial physiology
Endothelial cell physiology
Endothelial cells line the inner surface of blood vessels and
establish an active barrier between solid tissues and circu-
lating blood. Over the past few decades, this delicate cellular
monolayer has emerged as a highly specialized tissue that by
far exceeds the sole function of forming a passive physical
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interface [23]. Endothelial cells actively regulate an enor-
mous variety of physiological processes and thereby control
vascular tone and permeability, inflammatory responses,
leucocyte trafficking, platelet adhesion and hemostasis,
angiogenesis and wound healing as well as the exchange of
metabolites between blood and surrounding tissues (for a
review see Ref. [23]). The vascular endothelium also interacts
with other cell types such as vascular smooth muscle cells,
leukocytes, platelets, stem cells, pericytes, cardiomyocytes,
mesangial cells of the kidney and many more mainly through
the production of signaling and adhesion molecules [23]. For
example, nitric oxide (NO), prostacyclin, hyperpolarizing fac-
tor and endothelin, all generated in the endothelium, directly
modulate vascular smooth muscle contractility [98]. Secretion
of vonWillebrand factor causes platelet adhesion, while selec-
tins, produced by the endothelium, are responsible for the
recruitment of leukocytes during inflammation [23]. Hence,
even slight dysfunction of the endothelium can also compro-
mise the function of each of these cell types leading to inad-
equate vasoconstriction, leukocyte infiltration, coagulation,
permeability and increased proliferation or apoptosis [23],
all of which are key features found in a wide range of diseases
that represent the leading causes of death in the western world
[63].
Endothelial cells per se are quite heterogeneous and various
phenotypes meet the particular demand of the individual tissue
and/or organ [47, 48]. Some differences in endothelial archi-
tecture such as permeability and fenestration can be easily
deduced from differences in the specific function of the organs.
Others are not as obvious but become very clear in diseases
like atherosclerosis, vasculitis or even tumor metastasis that
oftenmanifest at preferential sites within the circulatory system
[23]. Endothelial cells of different origins might even show
diversity in mitochondrial physiology such as DNA repair
ability [33, 58].
Mitochondria: structure and function
The mitochondrion exhibits unique architecture, comprising
of an inner membrane encased by an outer membrane dividing
it into two distinct compartments [95]. The outer membrane,
separating the intermembranous space from the cytosol, is
permeable to most sorts of ions and small molecules via the
voltage-dependent anion-selective channel (VDAC) that has
been found, at least in liposomal preparations, to be activated
by high Ca2+ [8]. Ion flux through the inner mitochondrial
membrane (IMM), however, is tightly regulated by the activ-
ity of selective mitochondrial ion channels and exchangers
[93]. Along with these ion shuttling proteins, the IMM, which
forms out cristae in order to expand its surface, houses
a multitude of multiheteromeric protein complexes that
account for electron transport and oxidative phosphorylation
(OXPHOS) [125].
The microscopic anatomy of mitochondria within living
cells is fascinating by various means. Mitochondria are not at
all static organelles but move and continuously change their
appearance by fission, fusion and branching. The organelles
can appear as highly interconnected tubular structures forming
a complex network but also as smaller single beads or rods
within one given cell (Fig. 1). Fast remodeling of the overall
morphology of mitochondria is believed to be fundamental for
maintaining intact mitochondrial DNA (mtDNA), metabolic
function and signaling of these organelles [95, 108, 154]. The
dynamics of individual mitochondria within one given cell
can be very diverse (Supplementary movie 1), probably
depending on the connection to certain motor proteins [135]
and the cytoskeleton. This heterogeneity in the movements of
single mitochondria also impacts mitochondrial fusion–
fission dynamics [87] and might reflect differences in meta-
bolic activity and signaling of individual mitochondria.
Mitochondria exhibit tissue-specific characteristics includ-
ing their capacity of ATP production [32, 33, 118], their
number and distribution [107], and also, mechanisms of Ca2+
handling appear to vary between cell types [9, 34, 39, 72]. In
endothelial cells, mitochondria comprise less than 5% of total
cellular volume (Fig. 1) compared to around 28% in hepato-
cytes [13]. That and the point that endothelial cells do not
necessarily depend on OXPHOS in order to produce ATP
[118] have led to the fact that the role of mitochondria in
endothelial physiology and pathology has been underestimated
for a long time.
For many years, isolating mitochondria from fresh tissue
is a well-established technique to investigate specific pro-
cesses in a suspension of mitochondria [81]. However, in
vitro experiments are restricted to the evaluation of a few
basic functions that are preserved in purified mitochondria
such as ATP production and oxygen consumption. As men-
tioned above, these functions might not be among the most
prominent duties of mitochondria in the endothelium. Since
the development of genetically encoded sensors that enable
Fig. 1 3D-rendered micrograph visualizing the morphology of mito-
chondria (red) in the human umbilical vein endothelial cell line EA.
hy926
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the assessment of mitochondrial physiology in living cells,
mitochondria have emerged as signaling organelles with a
wide range of functions reaching far beyond the mere task of
ATP synthesis.
Mitochondria vividly interact with other organelles and con-
tribute substantially to endothelial Ca2+ signaling (reviewed in
Ref. [51]), ROS production, apoptosis, lipid metabolism and
autophagy. Even endothelial NO production is influenced by
mitochondrial Ca2+ handling [36].
Oxidative phosphorylation (OXPHOS)
OXPHOS, the aerobic production of ATP by mitochon-
dria, requires a stepwise oxidation of electron donors
reduced through catabolism of fuels comprising lipids,
amino acids and, most importantly to the endothelial cell,
carbohydrates. This depends on the orchestrated action of
huge multiheteromeric protein complexes anchored to the
IMM and encoded by both nuclear and mtDNA, common-
ly referred to as the mitochondrial electron transport chain
(ETC) [125].
Under most conditions, endothelial ATP supplies can be
covered by anaerobic metabolism of D-glucose, which ren-
ders endothelial OXPHOS an oxygen-consuming luxury and
rather counterproductive in supplying adjacent tissues with
sufficient oxygen [49]. However, low basal rates of oxygen
consumption, together with NO, might help the endothelium
in maintaining an adequate oxygen gradient around blood
vessels.
NO, produced by endothelial NO synthase (eNOS;
NOS-III), seems to have a central role in sensing O2
concentrations and controlling respiration as it binds and
inhibits complex IV of the ETC (cytochrome c oxidase)
in an O2-dependent manner. This inhibition is reversible
and inversely correlates with ambient O2 concentrations
[100]. Activation or inhibition of eNOS has been found
to cause corresponding alterations in mitochondrial oxygen
consumption [25]. This means that when local O2 concentra-
tions fall, NO produced by eNOS [153] causes vasodilation
but also restricts OXPHOS of endothelial and perivascular
cells, thus, allowing O2 to diffuse deeper into the tissue.
OXPHOS is the main source of ROS [102] and even though
the importance of OXPHOS to endothelial cells remains ques-
tionable, ROS of mitochondrial origin are discussed as key
factors in the pathophysiology of cardiovascular diseases [18,
89, 105]. A disproportionately high supply of metabolites and,
thus, also electron donors, is believed to overburden the mito-
chondrial ETC, thereby causing increased leakage of unpaired
electrons at preferential sites to O2 [89]. However, recent
studies describe enhanced endothelial ROS formation not only
under hyper- but also under hypoglycemic conditions [149],
which might raise some doubts about ROS being actually the
initial instigator of endothelial dysfunction.
Mitochondrial Ca2+ handling
Calcium ions stand out among other cations due to their ability
to act as secondmessengers and therebymodify an impressive
range of cellular processes. This can be achieved by reversible
binding of Ca2+ to different Ca2+-binding domains within a
variety of signaling proteins. Ca2+-induced conformational
changes of these specific proteins lead to alterations in enzyme
activity, subcellular localization and other properties [51] that
govern endothelial function. Considering the abundance of
cytosolic Ca2+-binding proteins and the basal intracellular Ca2+
concentration being relatively low with around 100 nM, it
becomes obvious that the diffusion coefficient of ionic Ca2+
in the cytosol is vanishingly small, making it a basic necessity
for the cell to form out Ca2+ signaling networks that help in
conducting the sophisticated interplay of subcellular Ca2+
handling. For a long time, mitochondria were considered to
act as a passive sink for Ca2+, storing it within the matrix
without any further activity, but over the last few years,
mitochondria have been found to actively take part in
cellular Ca2+ homeostasis. Although the main intracellular
source of Ca2+ is represented by the endoplasmic reticulum
(ER), mitochondria are estimated to account for at least
25% of total Ca2+ in endothelial cells [152] depending on
the state of cell activation. Together mitochondria and the
ER establish junctions to cooperate in the propagation of
Ca2+ signals [64, 121].
It is of crucial importance tomost types of cells that theCa2+
concentration in the ER ([Ca2+]ER) does not drop below a
certain level, since the activity of ER chaperones such as
calreticulin and calnexin strictly depends on free Ca2+ [26].
These lectin chaperones are responsible for proper assembly
and quality control of glycoproteins [26, 109]. Hence, a per-
sistent decrease in [Ca2+]ER causes protein misfolding, accu-
mulation of these proteins and activation of the unfolded
protein response and ER stress pathways [26], which have
been found to contribute to endothelial pathology [24]. In order
to avoid such a scenario, refilling of ER Ca2+ stores is accom-
plished by a highly efficient machinery that guarantees ade-
quate ER Ca2+ content in the endothelium even under
prolonged stimulation with inositol 1,4,5-triphosphate (IP3)-
generating agonists like histamine [92]. Endothelial mitochon-
dria are key components of this machinery as they readily take
up Ca2+ at the inner mouth of capacitative Ca2+ entry/ICRAC
channels which, together with the clustering of stromal inter-
action molecule 1 (STIM1), are highly sensitive to Ca2+ gra-
dients in their vicinity [94]. By actively decreasing local
cytosolic Ca2+ concentrations, mitochondria are able to pro-
mote the formation of STIM1 clusters and keep ICRAC channels
in the open conformation, thus, contributing to the maintenance
of store-operated Ca2+ entry (SOCE) in the endothelium [91,
92]. A similar phenomenon has been described in T lympho-
cytes [69]. In contrast, it has been shown that the ER Ca2+
Pflugers Arch - Eur J Physiol (2012) 464:63–76 65
content in adrenal glomerulosa cells is not preserved during
prolonged cell stimulation with an IP3-generating agonist [4],
despite a distinct activation of SOCE [122].
Nevertheless, the simultaneous increase in mitochondrial
Ca2+ concentration ([Ca2+]mito) enhances mitochondrial ATP
production, which is essential for Ca2+ uptake into the ER
through sarco/ER Ca2+-ATPase (SERCA) [112].
Unlike the ER, mitochondria do not store Ca2+ for longer
time periods, but rather help in funneling Ca2+ to the ER for
fast replenishment [92]. A similar modulation of ER refilling
by mitochondria can be observed in HeLa cells [2]. This also
explains the short duration of mitochondrial Ca2+ elevations
that is mainly influenced by a balance between the mitochon-
drial Ca2+ uniporter(s) (MCU) and the activity of the electro-
neutral mitochondrial Na+/Ca2+ exchanger (NCX) [91]. In
endothelial cells, inhibition of NCX by either pharmacological
compounds [91] or treatment with ROS [73] causes prolonged
mitochondrial Ca2+ elevation and, in consequence, also insuf-
ficient Ca2+ refilling of the ER during continuous stimulation,
the latter of which has been generally neglected so far. This
impairment of cellular Ca2+ signaling could conceivably
affect endothelial function and, in the worst case, both excess
mitochondrial Ca2+ and ER stress could trigger apoptotic
pathways. All of these are major culprits in the initiation of
cardiovascular diseases [24, 158], but still the molecular iden-
tities of many proteins involved in endothelial Ca2+ handling
are yet to be discovered.
In general, Ca2+ transport across the IMM is tightly regu-
lated by a set of proteins that include more or less Ca2+
selective ion channels (MCU, UCP2/3, mRyR), exchangers
(Letm1, NCLX) and regulatory proteins (MICU1) as well as
the nonselective mitochondrial permeability transition pore
(mPTP) [51]. In respiring mitochondria, Ca2+ flux through
the IMM is mainly driven by the enormous IMM potential
(ΔΨm) of around −180 mV that establishes a strong electro-
motive driving force for Ca2+ to enter the mitochondria via the
so-called MCU. This channel exhibits high selectivity for, but
rather low affinity to, Ca2+ ions [76]. The MCU’s KD of 10–
15 μM, originally described in studies on isolated cardiac
mitochondria [128], does not match the actual calcium signals
observed in living cells where cytosolic Ca2+ concentrations
are far lower, prompting the idea of cellular microdomains
with high local concentrations of calcium [60]. In endothelial
cells, such foci could conceivably be found at junctions
betweenmitochondria and the ER and close to ICRAC channels
in the subplasmalemmal space.
In line with this hypothesis is the finding that mitochondrial
motility is highly sensitive to cytosolic Ca2+. This phenome-
non can be observed in various cell types including endothelial
cells (Fig. 2, Supplementary movie 2). Recent studies in cell
lines derived from neuronal and cardiac tissues have identified
the Miro–Milton protein complex to account for the Ca2+
sensitivity of mitochondrial dynamics [86]. Containing two
EF hands, Miro has been shown to serve as a Ca2+ sensor
causing mitochondria to retain at sites of high cytosolic
Ca2+ concentrations [124] where they seem to participate
in buffering Ca2+ [91].
Anchoring mitochondria permanently to the inner plasma
membrane of endothelial cells decreased mitochondrial Ca2+
uptake in response to SOCE [104]; hence, one can assume that
mitochondria actively move to sites of Ca2+ entry. Local
buffering of entering Ca2+ by mitochondria yields global
mitochondrial Ca2+ transients during SOCE in the endothelium,
although only 10% of mitochondria are found in close vicinity
to subplasmalemmal STIM1 clusters [104]. Due to the morpho-
logical and functional heterogeneity of mitochondria (Fig. 1)
[15, 27], locally sequestered Ca2+ obviously cannot spread out
over the entire mitochondrial network. Consequently, other
mechanisms accounting for the propagation of mitochondrial
Ca2+ transients in the endothelium might exist including Ca2+
cycling between mitochondria and cytosol, as it has been pro-
posed for astrocytes [14].
This would also favor the existence of variable mecha-
nisms of mitochondrial calcium sequestration or some kind
of molecular switch that might adjust the Ca2+ affinity of the
MCU to different concentrations of cytosolic Ca2+. In endo-
thelial cells uncoupling protein 3 has been proposed to act as
such [145]. In fact, there are several proteins that have been
described to contribute to the phenomenon of mitochondrial
Fig. 2 Mitochondrial motility inversely correlates with the Ca2+ con-
centration ([Ca2+]) in ionomycin-permeabilized endothelial cells. Cells
expressing mtDsRed were incubated in a Ca2+-free buffer containing
10 μM ionomycin and 5 mM EGTA (0 Ca2+) for 3 min. Confocal
images (Δt01 s) of mtDsRed fluorescence were recorded under con-
ditions of 100 nM (n05), 300 nM (n05), 500 nM (n05) or 1000 nM
(n05) clamped free Ca2+ for 3 min. Mean mitochondrial motility for
each concentration was calculated by the number of mtDSRed-positive
pixels changing x–y location in between time points (Δt010 s). Values
indicate the percentage of mitochondrial motility relative to the mito-
chondrial motility under clamped Ca2+-free conditions and are repre-
sented as means±SEM. This analysis did not allow discrimination
between oscillatory and unidirectional movements
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Ca2+ uniport including uncoupling proteins 2 and 3 (UCP2/3)
[137, 138]. Just recently, after the identification of mitochon-
drial calcium uptake 1 (MICU1) as a regulatory subunit [114],
the actual pore-forming component of the MCU was discov-
ered [9, 34] in experiments using HeLa and HEK-293 cells as
well as isolated mouse liver mitochondria. Nevertheless, there
is data pointing to more than just one exclusive way of
mitochondrial Ca2+ uptake depending on the cell type as well
as the source of Ca2+ [72, 146, 147]. Electrophysiological
experiments have provided evidence for at least two distinct
calcium currents in the IMM of human cardiomyocytes [99]
and HeLa cells and three in endothelial cells [72]. In the
endothelium, UCP2/3 seem to be especially important for
the sequestration of Ca2+ released from the ER but not for
Ca2+ uptake during SOCE [138, 147]. In order to fully grasp
the differential regulation of these mechanisms, it will be a
basic necessity to employ a great variety of experimental
approaches and sophisticated techniques [72].
When Ca2+ passes through the mitochondrial matrix, it
leaves its traces influencing some key features of mitochon-
drial physiology that depend on the presence of free Ca2+.
The activity of some mitochondrial dehydrogenases has
been shown to require mitochondrial free Ca2+ [62]. This
Ca2+-dependent regulation of mitochondrial metabolism is
cell-specific and varies with the function of the cell [117].
Ca2+ can both directly activate enzymes of the TCA cycle
such as isocitrate dehydrogenase and 2-oxoglutarate dehy-
drogenase [96] and increase enzyme activity of pyruvate
dehydrogenase via Ca2+-dependent dephosphorylation
[37]. In that way, Ca2+ exerts its sustained modulatory
effects on mitochondrial ATP generation [74]. Cytosolic
Ca2+ signals being transferred into mitochondria probably
help the cell to keep up with increasing energy demands
under activated conditions. However, this feedback mecha-
nism also depends on the source of Ca2+ and the type of cell
[123]. The relevance of this pathway in the highly glycolytic
endothelial cell still remains unclear, but it seems possible
that cell activation also requires the recruitment of additional
ATP sources, which are negligible during resting states.
Another condition that accelerates mitochondrial metabo-
lism and thereby also generation of free radicals in the
endothelium is hyperglycemia [18]. Restriction of OXPHOS
by inhibiting MCU might provide future treatment options
for diabetic complications.
NO, an integral player in cardiovascular physiology, regu-
lates vascular smoothmuscle contraction, ion channel activity,
apoptosis and also oxygen consumption [12, 25, 143]
(reviewed in Ref. [46]). In fact, NO has been shown to reduce
ΔΨm [136] possibly by reversibly inhibiting complex IVof the
mitochondrial ETC [49] and modulating mPTP opening [17],
both of which could either be responsible for or a consequence
of an inhibition of mitochondrial Ca2+ uptake by NO [35].
Notably, a mitochondrial isoform of NO synthase is activated
by mitochondrial free Ca2+, representing a negative feedback
mechanism that has been proposed to protect against mito-
chondrial Ca2+ overload during exposure to high concentra-
tions of NO [36].
ROS production and redox signaling
Mitochondria represent one, if not the major, source of ROS
within most cell types. ROS are reactive compounds that can
originate as a by-product of OXPHOS, mainly as a result of
leakage of single unpaired electrons from the ETC reducing
molecular oxygen to generate superoxide anions. These super-
oxide radicals are readily converted into other ROS including
hydrogen peroxide, peroxynitrite and hydroxyl radicals [102].
At low levels, ROS are believed to play an essential role in
vascular signaling processes by regulating the activity of sig-
naling proteins, enzymes and ion channels in endothelial cells
[116, 132]. NO, for instance, the endothelium-derived relaxing
factor, being one of the most studied cellular signaling mole-
cules, is a free radical itself. Yet NO is essential to endothelial
function as it mediates vasodilation along with numerous other
physiological processes [46]. Other targets of mitochondrial
ROS signaling in endothelial as well as surrounding smooth
muscle cells are proliferation, hypertrophy and apoptosis [59].
On the other hand, an excess of ROS, if not detoxified, can
cause damage to macromolecules including DNA, proteins
and lipids, commonly referred to as oxidative stress. Altera-
tions in protein function and accumulation ofmodified proteins
as well as DNA strand breaks and mutations, over time lead to
cellular dysfunction and contribute to endothelial damage in
diseases like atherosclerosis and diabetes [18]. Under these
conditions, mitochondrial ROS clearly contribute to the initia-
tion of inflammatory pathways such as NF-κB activation in the
endothelial cell that, in turn, lead to the recruitment of leuco-
cytes to the vascular intima [111]. The subsequent oxidative
burst provoked by activated neutrophils is orders of magnitude
higher than endothelial ROS generation and usually results in
sustained damage to the endothelium [139].
The close connection between cellular ROS and Ca2+
signaling is reflected by the impact of ROS treatment on
mitochondrial Ca2+ handling in endothelial cells. Oxidative
stress provoked by either a H2O2 bolus or a combination of
hypoxanthine and xanthine oxidase potentiates mitochondrial
Ca2+ signals by inhibiting NCX [73]. This mechanism seems
to work in both ways, since mitochondrial Ca2+ transients can
also greatly increase the generation of free radicals [20]. One
example for the cooperation of mitochondrial Ca2+ and ROS
in endothelial cell signaling shall be depicted in the form of
their function in mechanotransduction. As mitochondria are
anchored to the cytoskeleton [85], they can sense shear stress
and increase ROS production in response [1]. A clear attenu-
ation of shear stress-induced ROS signaling and consecutive
expression of adhesion molecules were seen after selective
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inhibition of mitochondrial ROS production, while inhibition
of other ROS sources had no effect [1]. Another report
describes that increased blood pressure in the pulmonary
circulation leads to Ca2+ oscillations in the cytosol of endo-
thelial cells, which are transferred to the mitochondria where
they promote ROS production and thereby also exocytosis of
P-selectin [71].
Mitochondrial contribution to endothelial pathology
Controlled apoptosis in endothelial cell function
The development of new blood vessels as well as the regres-
sion of preexisting ones depend on the tightly regulated bal-
ance between proliferation and the controlled death of
endothelial cells [90]. Mitochondria have a critical function
in triggering this enzymatic cascade of self-destruction by
releasing a set of proteins into the cytosol [142]. This happens
in response to proapoptotic stimuli that can originate either
from inside the cell itself or from outside by activation of death
receptors. A lot of in vitro studies suggest that endothelial cell
apoptosis might play a special role in the pathophysiology of
micro- and macroangiopathy under certain conditions like
diabetes or hyperlipidemia [42, 144]. Unlike necrosis, apopto-
sis follows a stereotypical cascade of events that can be influ-
enced pharmacologically, which is why the identification of
the exact molecular mechanisms leading to endothelial cell
death is that important.
Mitochondrial pathways of apoptosis usually involve the
permeabilization of the OMM leading to a release of cyto-
chrome c from the intermembranous space into the cytosol
where it associates with other proteins including caspase 9 to
form the so-called apoptosome [61]. In many but not in all
cases, this is accompanied by the formation mPTP, a large
unselective pore spanning both IMM and OMM that allows
ions and small molecules to permeate, thus, causing a dissi-
pation ofΔΨm [22]. Inhibition of mPTP opening by treatment
with cyclosporine A seems to prevent cytochrome c release
and apoptosis in human endothelial cells [148], although in
other cell types release of cytochrome c has been reported to
occur upstream of mPTP opening [16].
Mitochondrial Ca2+ overload is one of the factors that
independently cause opening of mPTP. During sustained
elevations of cytosolic Ca2+, observed in multiple patholog-
ical conditions of the endothelium [134, 144], free Ca2+
inside the mitochondrial matrix progressively rises. In the
presence of cyclophilin D, this induces the formation of
mPTP [7] that is kept open as long as the cytosolic Ca2+
elevation persists. The pore allows solutes to freely diffuse
into the mitochondrial matrix leading to mitochondrial swell-
ing and rupture of the OMM followed by release of proapop-
totic factors [61].
Another mitochondrial pathway of apoptosis is character-
ized by the release of apoptosis-inducing factor (AIF), a
protein involved not only in apoptosis, but also in free radical
scavenging and OXPHOS. The translocation of AIF from the
IMM to the nucleus requires permeabilization of the OMM
and removal of the inner membrane anchoring segment, the
latter of which is achieved by activation of the Ca2+-dependent
protease calpain I [75]. This specific pathway of apoptosis was
reported to be implicated in endothelial cell loss in diabetic
retinopathy [83].
Atherosclerosis
Even though mtDNA encodes only 13 of all mitochondrial
proteins, there are associations of mtDNA damage [28] as
well as certain mtDNA haplogroups with coronary artery
disease and diabetic retinopathy [102]. Although some
of these associations are not confirmed by other studies
[51], they still highlight the importance of mitochondria in
cardiovascular disease. MtDNA is more prone to ROS-
induced damage than nuclear DNA because firstly, it is
in close vicinity to the ETC as the major source of ROS,
and secondly, it lacks many repair mechanisms of nuclear
DNA [29, 155].
In view of these reports, the question arises, if alterations of
mtDNA are just an indicator of oxidative damage or if they
also play a causative role in the process of atherogenesis
possibly preceding the formation of atherosclerotic lesions.
In this respect, the fact that not only acquired but also connate
mtDNA mutations predispose to cardiovascular disease
already points to mtDNA damage occurring at an early stage
of atherosclerosis, which is further supported by investiga-
tions in apolipoprotein E knockout (apoE−/−) mice [5]. What
is/are the initiating factor(s) causing mtDNA damage? Mito-
chondrial ROS production itself [45] as well as exogenously
administered ROS [6] have been shown to cause mtDNA
damage, impaired mitochondrial protein synthesis and ATP
production, thus creating a vicious circle of increasing oxidant
generation and decreasing mitochondrial function [59]. For
example, a complex I deficiency of the respiratory chain,
which can be caused by mutations in any of the genes encod-
ing a subunit of complex I, leads to excessive production of
superoxide [115].
While in diabetes it is mainly hyperglycemia that is believed
to account for the initial excess in mitochondrial ROS (see
“Diabetes”), another important etiologic factor in the develop-
ment of atherosclerotic lesions is the oxidative modification of
low density lipoprotein (LDL), which further promotes inflam-
matory responses of the endothelium [133]. It has been con-
vincingly demonstrated that certain lipid oxidation products
specifically accumulate in endothelial mitochondria [80] where
they seem to increase mitochondrial ROS production [160].
Apart from causing DNAdamage, inflammatory responses and
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a decline in mitochondrial function, oxidative stress also leads
to increased apoptosis [22, 78] and so does oxidized LDL
(oxLDL) in the endothelium [38, 44, 65]. Recently, a couple
of substances have been discovered that protect endothelial
cells against oxLDL-related apoptosis. For example, exoge-
nous administration of humanin, a peptide found in endothelial
mitochondria, can partly abrogate the effects of oxLDL [3].
Another study has shown that apoptosis, oxidative stress and
progression of atherosclerosis in apoE−/−mice can be positive-
ly influenced by treatment with humanin [106]. Further pro-
tective compounds include the natural phenol resveratrol, and
its analogs that are potent inducers of sirtuin gene expression
[159]. Some of these sirtuins, namely SIRT3, SIRT4 and
SIRT5 are found exclusively in the mitochondrial matrix where
SIRT3 acts as NAD+-dependent deacetylase, thereby directly
influencing energy metabolism. Other sirtuins that are not
located in the mitochondrion such as SIRT1 still have substan-
tial influence on mitochondrial biogenesis in the endothelium
[30].
The phenomenon of oxLDL-induced apoptosis of endo-
thelial cells in vitro, which was already described to depend
on Ca2+ [44], has more recently been found to involve both
caspase-dependent and caspase-independent mitochondrial
pathways [21, 144]. Noteworthy, cyclosporine A, which has
properties of inhibiting mPTP [157], has been shown to
reduce oxLDL-associated atherosclerosis [40] by preventing
the release of cytochrome c from mitochondria [148].
Interestingly, in cultured endothelial cells, the oxidation of
LDL itself correlates with mitochondrial superoxide produc-
tion and can be stopped by inhibition or uncoupling of the
ETC [88] pointing to a vicious circle that ultimately culmi-
nates in vascular pathologies.
Over the past few years, more and more experimental
evidence has accumulated that links mitochondrial dysfunction
to atherosclerosis (reviewed in more detail in Ref. [89]).
Diabetes
Diabetes mellitus is characterized by an elevation of blood
glucose caused by insulin resistance and/or deficiency, inmost
cases accompanied by hyperlipidemia. Due to their direct
exposure to the blood and all its components, endothelial cells
obviously represent the primary target of both hyperglycemia
as well as hyperlipidemia. Under these conditions, the endo-
thelium is practically overwhelmed by pathologically high
levels of D-glucose.
Since M. Brownlee proposed a unifying mechanism of
diabetic complications 10 years ago, endothelial mitochondria
have become a new focus in diabetes research [18, 19].
According to Brownlee’s hypothesis, an excess of D-glucose
in the endothelial cell is metabolized via glycolysis yielding
pyruvate that enters the mitochondria and feeds into the TCA
cycle providing an increasing amount of reducing equivalents
[151] and, thus, an increased flux of electrons through the
respiratory chain. As a consequence, mitochondrial superox-
ide production is boosted, causing oxidative damage to all
sorts of molecules including nuclear DNA. Subsequently,
mechanisms of DNA repair such as poly(ADP-ribose) poly-
merase (PARP) are activated, which further causes collateral
damage by decreasing the activity of GAPDH, a central
enzyme of glycolysis [41]. The accumulation of glycolytic
intermediates then promotes the different downstream path-
ways of hyperglycemic damage [18, 105].
With 30 mM, the D-glucose concentrations used in these
studies to mimic diabetic conditions were rather high com-
pared with the situation in humans. Considering that even
patients with slightly impaired glucose tolerance already face
significantly worse prognosis [131], it is tempting to speculate
that there might be additional factors eliciting endothelial
dysfunction, possibly including mitochondrial dysfunction
and ER stress as outlined above.
High D-glucose also provokes alterations in mitochondrial
dynamics [110] and Ca2+ signaling [56, 150] that might even
precede the ROS burst itself [52, 54] and, thus, represent
attractive targets for future therapeutic interventions [79].
Enhanced fragmentation of mitochondria is at least partly
caused by increased expression and activity of proteins medi-
ating mitochondrial fission such as fission-1 protein (Fis1) and
dynamin related protein-1 (Drp1) [130]. Silencing of either
of the corresponding genes reduces mitochondrial ROS
production and restores eNOS activity under hyperglycemic
conditions [130, 156].
Mitochondrial fission during treatment with high D-glucose
concomitantly causes a prolonged elevation of [Ca2+]mito up-
on stimulation with histamine [110], which might occur either
due to functional disconnection of fragmented mitochondria
from the ER or due to inhibition of mitochondrial NCX by
ROS [73] (Fig. 3). Persistent redistribution of Ca2+ between
subcellular compartments, in turn, can initiate unfolded pro-
tein response [26] and apoptosis [61] both of which are
observed in endothelial damage [24].
An enhancement of certain apoptotic pathways is seen in
cellular models of diabetic vascular disease [42] that might
also involve a caspase-independent/AIF-dependent pathway
[83]. Other studies have shown that the Ca2+-dependent
opening of mPTP participates in the death of human aortic
endothelial cells under hyperglycemic conditions [119].
From a therapeutic point of view, the antidiabetic agent
metformin is of special interest because in addition to its
metabolic effects, it prevents the opening of mPTP [31].
This might contribute to its effectiveness in preventing
cardiovascular endpoints [43]. Moreover, in hyperglycemia,
as in hyperlipidemia, mitochondrial oxidative stress can be
attenuated by treatment with resveratrol [141], probably
through induction of antioxidative defense mechanisms
within the cell [140].
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Lipotoxicity
Specific familial disorders and metabolic diseases such as
type 2 diabetes can cause a mismatch between lipid supply
and uptake capacity of the adipose tissue leading to increas-
ing levels of free fatty acids, triglycerides and cholesterol in
the blood plasma. Since the endothelium is not able to store
large amounts of lipids, pathologically elevated blood lipids
represent a tremendous metabolic challenge for endothelial
mitochondria and a threat to the organelle’s function and
integrity [53].
Proteins that are upregulated when fatty acid availability
exceeds mitochondrial oxidative capacity are UCP2 and 3 [66,
67]. UCP3 was initially proposed to be a skeletal muscle
isoform of the uncoupling protein family, responsible for mild
uncoupling and reduction of ROS. However, UCP3 as well as
UCP2 were also found to be present in endothelial mitochon-
dria where they integrate a broad range of signaling functions
including mitochondrial Ca2+ sequestration [55, 138, 145].
Beyond that, UCP2/3 were postulated to take part in the
export of fatty acid anions that can accumulate in the mito-
chondrial matrix during lipid overload, hence preventing them
from peroxidation [129]. Another group hypothesized that
UCPs protect mitochondria from lipid-induced damage rather
by removing lipid peroxides from the matrix [50]. In any case,
knockdown of UCP2 in high fat fed mice causes endothelial
dysfunction and aggravation of atherosclerosis [101], whereas
its overexpression decreases ROS production and endothelin-
1 gene expression while increasing eNOS levels [84]. Though
the molecular functions of UCP2/3 are still a matter of debate,
these proteins might represent promising candidates for ther-
apeutic interventions in endothelial dysfunction caused by
hyperlipidemia.
Ischemia and reperfusion injury
Compared to other cell types such as neurons or the myocar-
dium, the endothelium can tolerate long periods of ischemia
Fig. 3 Schematic illustration of trans-organelle Ca2+ signaling in endo-
thelial cells upon IP3-mediated intracellular Ca
2+ release and SOCE.
Black arrows indicate Ca2+ movements under physiological conditions
in response to endothelial cell stimulation with, e.g., histamine. Red lines
highlight pathological processes under substrate overload that cause
excessive mitochondrial ROS production and, in turn, alter organelle
Ca2+ homeostasis leading to endothelial cell dysfunction. CCECs capaci-
tative Ca2+ entry channels, ER endoplasmic reticulum (blue), H1 hista-
mine H1 receptor, IP3 inositol 1,4,5-triphosphate, IP3R IP3 receptor,MCU
mitochondrial Ca2+ uniporter, NCX mitochondrial Na+/Ca2+ exchanger,
SERCA sarco/endoplasmic reticulum Ca2+-ATPase, STIM1 stromal inter-
action molecule 1
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[77]. In view of their primarily anaerobic energy metabolism
[118], endothelial cells meet their energy demands even under
severe hypoxic conditions of less than 0.1 mmHg pO2 [97].
This is probably supported by further restriction of mitochon-
drial oxidative metabolism through a Ca2+- and NO-mediated
decrease in oxygen sensitivity of cytochrome c oxidase [25]
that, in turn, preserves O2 levels for surrounding aerobic tissue
that crucially depends on sufficient oxygen supply.
However, in contrast to their high resistance to ischemia,
endothelial cells seem to be particularly vulnerable during
reperfusion, as they are the first to undergo apoptosis starting
already after 5 min of reperfusion in isolated rat hearts [126].
The importance of endothelial mitochondria in this process is
highlighted by a report demonstrating that reperfusion injury in
endothelial cells is mediatedmainly via activation of caspase 9.
This points towards mitochondrial damage, whereas apoptosis
of cardiomyocytes was characterized by activation of caspase
8 [127]. So, what is it that damages endothelial mitochondria
not during ischemia, but rather after reperfusion?
The most widely discussed factor that is proposed to dam-
age endothelial mitochondria exclusively upon reperfusion
are ROS, which can originate from numerous sources during
reperfusion. The three most studied sources comprise the
enzymes xanthine oxidase, NADPH oxidase and, of course,
the mitochondrial ETC [113, 161]. While NADPH oxidase is
mainly found in inflammatory cells, which can infiltrate the
damaged tissue in large numbers after restoration of blood
flow, both xanthine oxidase and mitochondria have been
shown to contribute to postischemic ROS generation within
the endothelium [11, 57, 113, 120]. Interestingly, transgenic
mice overexpressing cytosolic CuZn–SOD show superior
protection against endothelial dysfunction after reperfusion
[68].
Repeated short episodes of ischemia, so-called ischemic
preconditioning, improve cell survival after subsequent severe
ischemia not only in cardiac muscle but also in the endotheli-
um [82]. This beneficial effect appears to be, at least in part,
mediated via ROS signaling. Free radical scavengers, on the
one hand, have protective properties when administered during
ischemia but, on the other hand, can abrogate the positive
effects of preconditioning [10]. It is still not known in how
far mitochondria contribute to preconditioning in the endothe-
lium, but considering their central role in redox signaling and
expression of adhesion molecules [1], all of which are affected
during reperfusion [82], it is tempting to speculate that mito-
chondria play a central role in reperfusion injury and might
represent promising targets for new therapeutic approaches.
Especially attractive as potential drug targets would be mito-
chondrial Ca2+ channels. The significance of mitochondrial
Ca2+ in endothelial reperfusion injury still requires further
investigation. One can expect, though, that cytosolic Ca2+
oscillations occurring during reoxygenation [70] are trans-
ferred into the mitochondria where they may trigger ROS
production [20] and exocytosis of adhesion molecules [71]
that, in turn, favor reperfusion-associated endothelial dysfunc-
tion and leukocyte infiltration.
Conclusion
Compared to other tissues, the endothelium has only few
mitochondria and their contribution to cellular energy pro-
duction is rather insignificant. Yet these organelles are of
central importance to endothelial function as they integrate a
broad spectrum of physiological processes including Ca2+
handling, redox signaling, mechanotransduction and apo-
ptosis, all of which are closely interrelated. Dysfunction of
endothelial mitochondria is considered to be a causative
factor in the pathophysiology of most cardiovascular diseases
and, thus, represents a promising target for future therapeutic
interventions. However, the complexity of mitochondrial sig-
naling pathways and interorganelle crosstalk is generally
underestimated and requires further studies in order to be
profoundly understood.
Acknowledgments We thank F. Enzinger for his excellent technical
assistance and Dr. C.J.S. Edgell (University of North Carolina, Chapel
Hill, NC, USA) for the EA.hy926 cells. This work was supported by the
Austrian Science Funds (FWF, F3010-B05, P21857-B18, P22553-B18
and P23490). Special thanks to M.R. Alam and T.-V. Nguyen for proof-
reading of the manuscript.
Open Access This article is distributed under the terms of the Crea-
tive Commons Attribution License which permits any use, distribution,
and reproduction in any medium, provided the original author(s) and
the source are credited.
References
1. Ali MH, Pearlstein DP, Mathieu CE, Schumacker PT (2004)
Mitochondrial requirement for endothelial responses to cyclic
strain: implications for mechanotransduction. Am J Physiol 287
(3):L486–L496. doi:10.1152/ajplung.00389.2003
2. Arnaudeau S, Kelley WL, Walsh JV Jr, Demaurex N (2001)
Mitochondria recycle Ca2+ to the endoplasmic reticulum and
prevent the depletion of neighboring endoplasmic reticulum
regions. J Biol Chem 276(31):29430–29439. doi:10.1074/jbc.
M103274200
3. Bachar AR, Scheffer L, Schroeder AS, Nakamura HK, Cobb LJ,
Oh YK, Lerman LO, Pagano RE, Cohen P, Lerman A (2010)
Humanin is expressed in human vascular walls and has a cyto-
protective effect against oxidized LDL-induced oxidative stress.
Cardiovasc Res 88(2):360–366. doi:cvq191
4. Balla T, Szebeny M, Kanyar B, Spat A (1985) Angiotensin II and
FCCP mobilizes calcium from different intracellular pools in
adrenal glomerulosa cells; analysis of calcium fluxes. Cell Calcium
6(4):327–342
5. Ballinger SW, Patterson C, Knight-Lozano CA, Burow DL, Conklin
CA, Hu Z, Reuf J, Horaist C, Lebovitz R, Hunter GC, McIntyre K,
Runge MS (2002) Mitochondrial integrity and function in athero-
genesis. Circulation 106(5):544–549
Pflugers Arch - Eur J Physiol (2012) 464:63–76 71
6. Ballinger SW, Patterson C, Yan CN, Doan R, Burow DL, Young
CG, Yakes FM, Van Houten B, Ballinger CA, Freeman BA, Runge
MS (2000) Hydrogen peroxide- and peroxynitrite-induced mito-
chondrial DNA damage and dysfunction in vascular endothelial
and smooth muscle cells. Circ Res 86(9):960–966
7. Basso E, Fante L, Fowlkes J, Petronilli V, Forte MA, Bernardi P
(2005) Properties of the permeability transition pore in mitochon-
dria devoid of Cyclophilin D. J Biol Chem 280(19):18558–
18561. doi:C500089200
8. Bathori G, Csordas G, Garcia-Perez C, Davies E, Hajnoczky G
(2006) Ca2+-dependent control of the permeability properties of
the mitochondrial outer membrane and voltage-dependent anion-
selective channel (VDAC). J Biol Chem 281(25):17347–17358.
doi:M600906200
9. Baughman JM, Perocchi F, Girgis HS, PlovanichM, Belcher-Timme
CA, Sancak Y, Bao XR, Strittmatter L, Goldberger O, Bogorad RL,
Koteliansky V, Mootha VK (2011) Integrative genomics identifies
MCU as an essential component of the mitochondrial calcium uni-
porter. Nature 476(7360):341–345. doi:nature10234
10. Beauchamp P, Richard V, Tamion F, Lallemand F, Lebreton JP,
Vaudry H, Daveau M, Thuillez C (1999) Protective effects of
preconditioning in cultured rat endothelial cells: effects on neu-
trophil adhesion and expression of ICAM-1 after anoxia and
reoxygenation. Circulation 100(5):541–546
11. Beetsch JW, Park TS, Dugan LL, Shah AR, Gidday JM (1998)
Xanthine oxidase-derived superoxide causes reoxygenation injury
of ischemic cerebral endothelial cells. Brain Res 786(1–2):89–95.
doi:S0006-8993(97)01407-8
12. Beltran B, Mathur A, Duchen MR, Erusalimsky JD, Moncada S
(2000) The effect of nitric oxide on cell respiration: a key to
understanding its role in cell survival or death. Proc Natl Acad Sci
USA 97(26):14602–14607. doi:10.1073/pnas.97.26.14602
13. Blouin A, Bolender RP, Weibel ER (1977) Distribution of organ-
elles and membranes between hepatocytes and nonhepatocytes in
the rat liver parenchyma. A stereological study. J Cell Biol 72
(2):441–455
14. Boitier E, Rea R, Duchen MR (1999) Mitochondria exert a
negative feedback on the propagation of intracellular Ca2+ waves
in rat cortical astrocytes. J Cell Biol 145(4):795–808
15. Bootman MD, Lipp P, Berridge MJ (2001) The organisation
and functions of local Ca2+ signals. J Cell Sci 114(Pt 12):2213–
2222
16. Bossy-Wetzel E, Newmeyer DD, Green DR (1998) Mitochondrial
cytochrome c release in apoptosis occurs upstream of DEVD-
specific caspase activation and independently of mitochondrial trans-
membrane depolarization. EMBO J 17(1):37–49. doi:10.1093/emboj/
17.1.37
17. Brookes PS, Salinas EP, Darley-Usmar K, Eiserich JP, Freeman
BA, Darley-Usmar VM, Anderson PG (2000) Concentration-
dependent effects of nitric oxide on mitochondrial permeability
transition and cytochrome c release. J Biol Chem 275(27):20474–
20479. doi:10.1074/jbc.M001077200
18. Brownlee M (2001) Biochemistry and molecular cell biology of
diabetic complications. Nature 414(6865):813–820. doi:10.1038/
414813a
19. Brownlee M (2005) The pathobiology of diabetic complications:
a unifying mechanism. Diabetes 54(6):1615–1625. doi:54/6/1615
20. Camello-Almaraz C, Gomez-Pinilla PJ, Pozo MJ, Camello PJ
(2006) Mitochondrial reactive oxygen species and Ca2+ signaling.
Am J Physiol 291(5):C1082–C1088. doi:00217.2006
21. Chen J, Mehta JL, Haider N, Zhang X, Narula J, Li D (2004)
Role of caspases in Ox-LDL-induced apoptotic cascade in human
coronary artery endothelial cells. Circ Res 94(3):370–376.
doi:10.1161/01.RES.0000113782.07824.BE
22. Choy JC, Granville DJ, Hunt DW, McManus BM (2001) Endothe-
lial cell apoptosis: biochemical characteristics and potential
implications for atherosclerosis. J Mol Cell Cardiol 33(9):1673–
1690. doi:10.1006/jmcc.2001.1419
23. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA,
McEver RP, Pober JS, Wick TM, Konkle BA, Schwartz BS,
Barnathan ES, McCrae KR, Hug BA, Schmidt AM, Stern DM
(1998) Endothelial cells in physiology and in the pathophysiolo-
gy of vascular disorders. Blood 91(10):3527–3561
24. CivelekM,Manduchi E, Riley RJ, Stoeckert CJ Jr, Davies PF (2009)
Chronic endoplasmic reticulum stress activates unfolded protein re-
sponse in arterial endothelium in regions of susceptibility to athero-
sclerosis. Circ Res 105(5):453–461. doi:CIRCRESAHA.109.203711
25. Clementi E, Brown GC, Foxwell N, Moncada S (1999) On the
mechanism by which vascular endothelial cells regulate their
oxygen consumption. Proc Natl Acad Sci USA 96(4):1559–1562
26. Coe H, Michalak M (2009) Calcium binding chaperones of the
endoplasmic reticulum. Gen Physiol Biophys 28(Spec No
Focus): F96–F103
27. Collins TJ, Berridge MJ, Lipp P, Bootman MD (2002) Mitochon-
dria are morphologically and functionally heterogeneous within
cells. EMBO J 21(7):1616–1627. doi:10.1093/emboj/21.7.1616
28. Corral-Debrinski M, Shoffner JM, Lott MT, Wallace DC (1992)
Association of mitochondrial DNA damage with aging and coro-
nary atherosclerotic heart disease. Mutat Res 275(3–6):169–180
29. Croteau DL, Stierum RH, Bohr VA (1999) Mitochondrial DNA
repair pathways. Mutat Res 434(3):137–148
30. Csiszar A, Labinskyy N, Pinto JT, Ballabh P, Zhang H, Losonczy
G, Pearson K, de Cabo R, Pacher P, Zhang C, Ungvari Z (2009)
Resveratrol induces mitochondrial biogenesis in endothelial cells.
Am J Physiol 297(1):H13–H20. doi:00368.2009
31. Csordas G, Varnai P, Golenar T, Sheu SS, Hajnoczky G (2011)
Calcium transport across the inner mitochondrial membrane:
molecular mechanisms and pharmacology. Mol Cell Endocrinol
(in press). doi: S0303-7207(11)00664-2
32. Culic O, Gruwel ML, Schrader J (1997) Energy turnover of
vascular endothelial cells. Am J Physiol 273(1 Pt 1):C205–C213
33. Davidson SM, Duchen MR (2007) Endothelial mitochondria:
contributing to vascular function and disease. Circ Res 100
(8):1128–1141. doi:10.1161/01.RES.0000261970.18328.1d
34. De Stefani D, Raffaello A, Teardo E, Szabo I, Rizzuto R (2011) A
forty-kilodalton protein of the inner membrane is the mitochondrial
calcium uniporter. Nature 476(7360):336–340. doi:nature10230
35. Dedkova EN, Blatter LA (2005) Modulation of mitochondrial
Ca2+ by nitric oxide in cultured bovine vascular endothelial cells.
Am J Physiol 289(4):C836–C845. doi:00011.2005
36. Dedkova EN, Ji X, Lipsius SL, Blatter LA (2004) Mitochondrial
calcium uptake stimulates nitric oxide production in mitochondria
of bovine vascular endothelial cells. Am J Physiol 286(2):C406–
C415. doi:10.1152/ajpcell.00155.2003
37. Denton RM, Randle PJ, Martin BR (1972) Stimulation by calcium
ions of pyruvate dehydrogenase phosphate phosphatase. Biochem J
128(1):161–163
38. Dimmeler S, Haendeler J, Galle J, Zeiher AM (1997) Oxidized
low-density lipoprotein induces apoptosis of human endothelial
cells by activation of CPP32-like proteases. A mechanistic clue to
the ‘response to injury’ hypothesis. Circulation 95(7):1760–1763
39. Drago I, Pizzo P, Pozzan T (2011) After half a century mitochon-
drial calcium in- and efflux machineries reveal themselves.
EMBO J 30(20):4119–4125. doi:emboj2011337
40. Drew AF, Tipping PG (1995) Cyclosporine treatment reduces
early atherosclerosis in the cholesterol-fed rabbit. Atherosclerosis
116(2):181–189. doi:0021915095055399
41. Du X, Matsumura T, Edelstein D, Rossetti L, Zsengeller Z, Szabo
C, Brownlee M (2003) Inhibition of GAPDH activity by poly
(ADP-ribose) polymerase activates three major pathways of
hyperglycemic damage in endothelial cells. J Clin Invest 112
(7):1049–1057. doi:10.1172/JCI18127
72 Pflugers Arch - Eur J Physiol (2012) 464:63–76
42. Du XL, Sui GZ, Stockklauser-Farber K,Weiss J, Zink S, Schwippert
B, Wu QX, Tschope D, Rosen P (1998) Introduction of apoptosis by
high proinsulin and glucose in cultured human umbilical vein endo-
thelial cells is mediated by reactive oxygen species. Diabetologia 41
(3):249–256
43. Effect of intensive blood-glucose control with metformin on
complications in overweight patients with type 2 diabetes
(UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group
(1998). Lancet 352(9131):854-865. doi: S0140673698070378
44. Escargueil-Blanc I, Meilhac O, Pieraggi MT, Arnal JF, Salvayre
R, Negre-Salvayre A (1997) Oxidized LDLs induce massive
apoptosis of cultured human endothelial cells through a
calcium-dependent pathway. Prevention by aurintricarboxylic acid.
Arterioscler Thromb Vasc Biol 17(2):331–339
45. Esposito LA, Melov S, Panov A, Cottrell BA, Wallace DC (1999)
Mitochondrial disease in mouse results in increased oxidative
stress. Proc Natl Acad Sci USA 96(9):4820–4825
46. Gao Y (2010) The multiple actions of NO. Pflugers Arch 459
(6):829–839. doi:10.1007/s00424-009-0773-9
47. Garlanda C, Dejana E (1997) Heterogeneity of endothelial cells.
Specific markers. Arterioscler Thromb Vasc Biol 17(7):1193–
1202
48. Gerritsen ME (1987) Functional heterogeneity of vascular endo-
thelial cells. Biochem Pharmacol 36(17):2701–2711. doi:0006-
2952(87)90252-8
49. Gladwin MT, Shiva S (2009) The ligand binding battle at cyto-
chrome c oxidase: how NO regulates oxygen gradients in tissue.
Circ Res 104(10):1136–1138. doi:104/10/1136
50. Goglia F, Skulachev VP (2003) A function for novel uncoupling
proteins: antioxidant defense of mitochondrial matrix by translocat-
ing fatty acid peroxides from the inner to the outer membrane
leaflet. FASEB J 17(12):1585–1591. doi:10.1096/fj.03-0159hyp
51. Graier WF, Frieden M, Malli R (2007) Mitochondria and Ca2+
signaling: old guests, new functions. Pflugers Arch 455(3):375–
396. doi:10.1007/s00424-007-0296-1
52. Graier WF, Hoebel BG, Paltauf-Doburzynska J, Kostner GM
(1998) Effects of superoxide anions on endothelial Ca2+ signaling
pathways. Arterioscler Thromb Vasc Biol 18(9):1470–1479
53. Graier WF, Malli R, Kostner GM (2009) Mitochondrial protein
phosphorylation: instigator or target of lipotoxicity? Trends
Endocrinol Metab 20(4):186–193. doi:S1043-2760(09)00040-X
54. Graier WF, Simecek S, Kukovetz WR, Kostner GM (1996)
D-glucose-induced changes in endothelial Ca2+/EDRF signal-
ing are due to generation of superoxide anions. Diabetes 45
(10):1386–1395
55. Graier WF, Trenker M, Malli R (2008) Mitochondrial Ca2+, the
secret behind the function of uncoupling proteins 2 and 3? Cell
Calcium 44(1):36–50. doi:S0143-4160(08)00004-3
56. Graier WF, Wascher TC, Lackner L, Toplak H, Krejs GJ, Kukovetz
WR (1993) Exposure to elevated D-glucose concentrations modu-
lates vascular endothelial cell vasodilatory response. Diabetes 42
(10):1497–1505
57. Greene EL, Paller MS (1992) Xanthine oxidase produces O2−. in
posthypoxic injury of renal epithelial cells. Am J Physiol 263(2 Pt
2):F251–F255
58. Grishko V, Solomon M, Wilson GL, LeDoux SP, Gillespie MN
(2001) Oxygen radical-induced mitochondrial DNA damage and
repair in pulmonary vascular endothelial cell phenotypes. Am J
Physiol 280(6):L1300–L1308
59. Gutierrez J, Ballinger SW, Darley-Usmar VM, Landar A (2006)
Free radicals, mitochondria, and oxidized lipids: the emerging
role in signal transduction in vascular cells. Circ Res 99(9):924–
932. doi:99/9/924
60. Hajnoczky G, Csordas G (2010) Calcium signalling: fishing out
molecules of mitochondrial calcium transport. Curr Biol 20(20):
R888–R891. doi:S0960-9822(10)01153-X
61. Hajnoczky G, Csordas G, Das S, Garcia-Perez C, SaotomeM, Sinha
Roy S, YiM (2006)Mitochondrial calcium signalling and cell death:
approaches for assessing the role of mitochondrial Ca2+ uptake in
apoptosis. Cell Calcium 40(5–6):553–560. doi:S0143-4160(06)
00181-3
62. Hajnoczky G, Robb-Gaspers LD, Seitz MB, Thomas AP (1995)
Decoding of cytosolic calcium oscillations in the mitochondria.
Cell 82(3):415–424. doi:0092-8674(95)90430-1
63. Hansson GK (2005) Inflammation, atherosclerosis, and coronary
artery disease. N Engl J Med 352(16):1685–1695. doi:352/16/
1685
64. Hayashi T, Rizzuto R, Hajnoczky G, Su TP (2009) MAM: more
than just a housekeeper. Trends Cell Biol 19(2):81–88. doi:
S0962-8924(08)00284-5
65. Hessler JR, Robertson AL Jr, Chisolm GM 3rd (1979) LDL-
induced cytotoxicity and its inhibition by HDL in human vascular
smooth muscle and endothelial cells in culture. Atherosclerosis
32(3):213–229. doi:0021-9150(79)90166-7
66. Hoeks J, Hesselink MK, Schrauwen P (2006) Involvement of
UCP3 in mild uncoupling and lipotoxicity. Exp Gerontol 41
(7):658–662. doi:S0531-5565(06)00040-4
67. Hoeks J, Hesselink MK, van Bilsen M, Schaart G, van der Vusse
GJ, Saris WH, Schrauwen P (2003) Differential response of
UCP3 to medium versus long chain triacylglycerols; manifesta-
tion of a functional adaptation. FEBS Lett 555(3):631–637
68. Horie Y, Wolf R, Flores SC, McCord JM, Epstein CJ,
Granger DN (1998) Transgenic mice with increased copper/zinc-
superoxide dismutase activity are resistant to hepatic leukostasis
and capillary no-reflow after gut ischemia/reperfusion. Circ Res 83
(7):691–696
69. Hoth M, Button DC, Lewis RS (2000) Mitochondrial control of
calcium-channel gating: a mechanism for sustained signaling and
transcriptional activation in T lymphocytes. Proc Natl Acad Sci
USA 97(19):10607–10612. doi:10.1073/pnas.180143997
70. Hu Q, Ziegelstein RC (2000) Hypoxia/reoxygenation stimulates
intracellular calcium oscillations in human aortic endothelial
cells. Circulation 102(20):2541–2547
71. Ichimura H, Parthasarathi K, Quadri S, Issekutz AC, Bhattacharya J
(2003) Mechano-oxidative coupling by mitochondria induces
proinflammatory responses in lung venular capillaries. J Clin Invest
111(5):691–699. doi:10.1172/JCI17271
72. Jean-Quartier C, Bondarenko AI, Alam MR, Trenker M,
Waldeck-Weiermair M, Malli R, Graier WF (2011) Studying
mitochondrial Ca2+ uptake—a revisit. Mol Cell Endocrinol (in
press). doi: S0303-7207(11)00650-2
73. Jornot L, Maechler P, Wollheim CB, Junod AF (1999) Reactive
oxygen metabolites increase mitochondrial calcium in endothelial
cells: implication of the Ca2+/Na+ exchanger. J Cell Sci 112
(Pt 7):1013–1022
74. Jouaville LS, Pinton P, Bastianutto C, Rutter GA, Rizzuto R
(1999) Regulation of mitochondrial ATP synthesis by calcium:
evidence for a long-term metabolic priming. Proc Natl Acad Sci
USA 96(24):13807–13812
75. Joza N, Pospisilik JA, Hangen E, Hanada T, Modjtahedi N,
Penninger JM, Kroemer G (2009) AIF: not just an apoptosis-
inducing factor. Ann N YAcad Sci 1171:2–11. doi:NYAS4681
76. Kirichok Y, Krapivinsky G, Clapham DE (2004) The mitochon-
drial calcium uniporter is a highly selective ion channel. Nature
427(6972):360–364. doi:10.1038/nature02246
77. Kloner RA, Rude RE, Carlson N, Maroko PR, DeBoer LW,
Braunwald E (1980) Ultrastructural evidence of microvascular
damage and myocardial cell injury after coronary artery occlusion:
which comes first? Circulation 62(5):945–952
78. Kokoszka JE, Coskun P, Esposito LA, Wallace DC (2001)
Increased mitochondrial oxidative stress in the Sod2(+/−) mouse
results in the age-related decline of mitochondrial function
Pflugers Arch - Eur J Physiol (2012) 464:63–76 73
culminating in increased apoptosis. Proc Natl Acad Sci USA 98
(5):2278–2283. doi:10.1073/pnas.051627098
79. Lackner LL, Nunnari J (2010) Small molecule inhibitors of
mitochondrial division: tools that translate basic biological
research into medicine. Chem Biol 17(6):578–583. doi:S1074-5521
(10)00201-2
80. Landar A, Zmijewski JW, Dickinson DA, Le Goffe C, JohnsonMS,
Milne GL, Zanoni G, Vidari G, Morrow JD, Darley-Usmar VM
(2006) Interaction of electrophilic lipid oxidation products with
mitochondria in endothelial cells and formation of reactive oxygen
species. Am J Physiol 290(5):H1777–H1787. doi:01087.2005
81. Lanza IR, Nair KS (2009) Functional assessment of isolated
mitochondria in vitro. Methods Enzymol 457:349–372. doi:
S0076-6879(09)05020-4
82. Laude K, Beauchamp P, Thuillez C, Richard V (2002) Endothelial
protective effects of preconditioning. Cardiovasc Res 55(3):466–
473. doi:S0008636302002778
83. Leal EC, Aveleira CA, Castilho AF, Serra AM, Baptista FI,
Hosoya K, Forrester JV, Ambrosio AF (2009) High glucose and
oxidative/nitrosative stress conditions induce apoptosis in retinal
endothelial cells by a caspase-independent pathway. Exp Eye Res
88(5):983–991. doi:S0014-4835(08)00446-6
84. Lee KU, Lee IK, Han J, Song DK, Kim YM, Song HS, Kim HS,
Lee WJ, Koh EH, Song KH, Han SM, Kim MS, Park IS, Park JY
(2005) Effects of recombinant adenovirus-mediated uncoupling
protein 2 overexpression on endothelial function and apoptosis.
Circ Res 96(11):1200–1207. doi:01.RES.0000170075.73039.5b
85. Lin A, Krockmalnic G, Penman S (1990) Imaging cytoskeleton–
mitochondrial membrane attachments by embedment-free electron
microscopy of saponin-extracted cells. Proc Natl Acad Sci USA 87
(21):8565–8569
86. Liu X, Hajnoczky G (2009) Ca2+-dependent regulation of mito-
chondrial dynamics by the Miro–Milton complex. Int J Biochem
Cell Biol 41(10):1972–1976. doi:S1357-2725(09)00170-8
87. Liu X, Weaver D, Shirihai O, Hajnoczky G (2009) Mitochondrial
‘kiss-and-run’: interplay between mitochondrial motility and
fusion-fission dynamics. EMBO J 28(20):3074–3089. doi:
emboj2009255
88. Mabile L, Meilhac O, Escargueil-Blanc I, Troly M, Pieraggi MT,
Salvayre R, Negre-Salvayre A (1997) Mitochondrial function is
involved in LDL oxidation mediated by human cultured endothelial
cells. Arterioscler Thromb Vasc Biol 17(8):1575–1582
89. Madamanchi NR, Runge MS (2007) Mitochondrial dysfunction
in atherosclerosis. Circ Res 100(4):460–473. doi:10.1161/01.
res.0000258450.44413.96
90. Mallat Z, Tedgui A (2000) Apoptosis in the vasculature: mecha-
nisms and functional importance. Br J Pharmacol 130(5):947–962.
doi:10.1038/sj.bjp.0703407
91. Malli R, Frieden M, Osibow K, Zoratti C, Mayer M, Demaurex
N, Graier WF (2003) Sustained Ca2+ transfer across mitochondria
is essential for mitochondrial Ca2+ buffering, sore-operated Ca2+
entry, and Ca2+ store refilling. J Biol Chem 278(45):44769–
44779. doi:10.1074/jbc.M302511200
92. Malli R, Frieden M, Trenker M, Graier WF (2005) The role of
mitochondria for Ca2+ refilling of the endoplasmic reticulum. J
Biol Chem 280(13):12114–12122. doi:M409353200
93. Malli R, Graier WF (2010) Mitochondrial Ca2+ channels: great
unknowns with important functions. FEBS Lett 584(10):1942–
1947. doi:S0014-5793(10)00027-X
94. Malli R, Naghdi S, Romanin C, Graier WF (2008) Cytosolic Ca2+
prevents the subplasmalemmal clustering of STIM1: an intrinsic
mechanism to avoid Ca2+ overload. J Cell Sci 121(Pt 19):3133–
3139. doi:jcs.034496
95. McBride HM, Neuspiel M, Wasiak S (2006) Mitochondria: more
than just a powerhouse. Curr Biol 16(14):R551–R560. doi:
S0960-9822(06)01781-7
96. McCormack JG, Denton RM (1979) The effects of calcium ions and
adenine nucleotides on the activity of pig heart 2-oxoglutarate
dehydrogenase complex. Biochem J 180(3):533–544
97. Mertens S, Noll T, Spahr R, Krutzfeldt A, Piper HM (1990)
Energetic response of coronary endothelial cells to hypoxia. Am
J Physiol 258(3 Pt 2):H689–H694
98. Michel T, Vanhoutte PM (2010) Cellular signaling and NO produc-
tion. Pflugers Arch 459(6):807–816. doi:10.1007/s00424-009-
0765-9
99. Michels G, Khan IF, Endres-Becker J, Rottlaender D, Herzig S,
Ruhparwar A, Wahlers T, Hoppe UC (2009) Regulation of the
human cardiac mitochondrial Ca2+ uptake by 2 different voltage-
gated Ca2+ channels. Circulation 119(18):2435–2443. doi:
CIRCULATIONAHA.108.835389
100. Moncada S, Erusalimsky JD (2002) Does nitric oxide modulate
mitochondrial energy generation and apoptosis? Nat Rev Mol
Cell Biol 3(3):214–220. doi:10.1038/nrm762
101. Moukdar F, Robidoux J, Lyght O, Pi J, Daniel KW, Collins S
(2009) Reduced antioxidant capacity and diet-induced atheroscle-
rosis in uncoupling protein-2-deficient mice. J Lipid Res 50
(1):59–70. doi:M800273-JLR200
102. Murphy MP (2009) How mitochondria produce reactive oxygen
species. Biochem J 417(1):1–13. doi:BJ20081386
103. Murray CJ, Lopez AD (1997) Global mortality, disability, and the
contribution of risk factors: Global Burden of Disease Study.
Lancet 349(9063):1436–1442. doi:S0140-6736(96)07495-8
104. Naghdi S, Waldeck-Weiermair M, Fertschai I, Poteser M, Graier
WF, Malli R (2010) Mitochondrial Ca2+ uptake and not mitochon-
drial motility is required for STIM1-Orai1-dependent store-operated
Ca2+ entry. J Cell Sci 123(Pt 15):2553–2564. doi:jcs.070151
105. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T,
Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino
I, Brownlee M (2000) Normalizing mitochondrial superoxide
production blocks three pathways of hyperglycaemic damage.
Nature 404(6779):787–790. doi:10.1038/35008121
106. Oh YK, Bachar AR, Zacharias DG, Kim SG, Wan J, Cobb LJ,
Lerman LO, Cohen P, Lerman A (2011) Humanin preserves
endothelial function and prevents atherosclerotic plaque progres-
sion in hypercholesterolemic ApoE deficient mice. Atherosclerosis
219(1):65–73. doi:S0021-9150(11)00560-0
107. Oldendorf WH, Brown WJ (1975) Greater number of capillary
endothelial cell mitochondria in brain than in muscle. Proc Soc
Exp Biol Med 149(3):736–738
108. Ono T, Isobe K, Nakada K, Hayashi JI (2001) Human cells are
protected from mitochondrial dysfunction by complementation of
DNA products in fused mitochondria. Nat Genet 28(3):272–275.
doi:10.1038/90116
109. Osibow K, Frank S, Malli R, Zechner R, Graier WF (2006)
Mitochondria maintain maturation and secretion of lipoprotein
lipase in the endoplasmic reticulum. Biochem J 396(1):173–182.
doi:BJ20060099
110. Paltauf-Doburzynska J, Malli R, Graier WF (2004) Hyperglycemic
conditions affect shape and Ca2+ homeostasis of mitochondria in
endothelial cells. J Cardiovasc Pharmacol 44(4):423–436.
doi:00005344-200410000-00003
111. Pamukcu B, Lip GY, Shantsila E (2011) The nuclear factor–kappa
B pathway in atherosclerosis: a potential therapeutic target for
atherothrombotic vascular disease. Thromb Res 128(2):117–123.
doi:S0049-3848(11)00152-6
112. Parekh AB (2008) Mitochondrial regulation of store-operated
CRAC channels. Cell Calcium 44(1):6–13. doi:S0143-4160(07)
00205-9
113. Pearlstein DP, Ali MH, Mungai PT, Hynes KL, Gewertz BL,
Schumacker PT (2002) Role of mitochondrial oxidant generation
in endothelial cell responses to hypoxia. Arterioscler Thromb
Vasc Biol 22(4):566–573
74 Pflugers Arch - Eur J Physiol (2012) 464:63–76
114. Perocchi F, Gohil VM, Girgis HS, Bao XR, McCombs JE, Palmer
AE, Mootha VK (2011) MICU1 encodes a mitochondrial EF
hand protein required for Ca2+ uptake. Nature 467(7313):291–
296. doi:nature09358
115. Pitkanen S, Robinson BH (1996) Mitochondrial complex I defi-
ciency leads to increased production of superoxide radicals and
induction of superoxide dismutase. J Clin Invest 98(2):345–351.
doi:10.1172/JCI118798
116. Poteser M, Graziani A, Rosker C, Eder P, Derler I, Kahr H, Zhu
MX, Romanin C, Groschner K (2006) TRPC3 and TRPC4 associ-
ate to form a redox-sensitive cation channel. Evidence for expres-
sion of native TRPC3–TRPC4 heteromeric channels in endothelial
cells. J Biol Chem 281(19):13588–13595. doi:M512205200
117. Pralong WF, Spat A, Wollheim CB (1994) Dynamic pacing of
cell metabolism by intracellular Ca2+ transients. J Biol Chem 269
(44):27310–27314
118. Quintero M, Colombo SL, Godfrey A, Moncada S (2006) Mito-
chondria as signaling organelles in the vascular endothelium.
Proc Natl Acad Sci USA 103(14):5379–5384. doi:0601026103
119. Recchioni R, Marcheselli F, Moroni F, Pieri C (2002) Apoptosis
in human aortic endothelial cells induced by hyperglycemic
condition involves mitochondrial depolarization and is pre-
vented by N-acetyl-L-cysteine. Metabolism 51(11):1384–1388.
doi:S0026049502001002
120. Rieger JM, Shah AR, Gidday JM (2002) Ischemia–reperfusion
injury of retinal endothelium by cyclooxygenase- and xanthine
oxidase-derived superoxide. Exp Eye Res 74(4):493–501.
doi:10.1006/exer.2001.1156
121. Rizzuto R, Pinton P, Carrington W, Fay FS, Fogarty KE, Lifshitz
LM, Tuft RA, Pozzan T (1998) Close contacts with the endoplasmic
reticulum as determinants of mitochondrial Ca2+ responses. Science
280(5370):1763–1766
122. Rohacs T, Bago A, Deak F, Hunyady L, Spat A (1994) Capacitative
Ca2+ influx in adrenal glomerulosa cells: possible role in angioten-
sin II response. Am J Physiol 267(5 Pt 1):C1246–C1252
123. Rohacs T, Nagy G, Spat A (1997) Cytoplasmic Ca2+ signalling
and reduction of mitochondrial pyridine nucleotides in adrenal
glomerulosa cells in response to K+, angiotensin II and vasopressin.
Biochem J 322(Pt 3):785–792
124. Saotome M, Safiulina D, Szabadkai G, Das S, Fransson A, Aspen-
strom P, Rizzuto R, Hajnoczky G (2008) Bidirectional Ca2+-depen-
dent control of mitochondrial dynamics by the Miro GTPase. Proc
Natl Acad Sci USA 105(52):20728–20733. doi:0808953105
125. Saraste M (1999) Oxidative phosphorylation at the fin de siecle.
Science 283(5407):1488–1493
126. Scarabelli T, Stephanou A, Rayment N, Pasini E, Comini L,
Curello S, Ferrari R, Knight R, Latchman D (2001) Apoptosis
of endothelial cells precedes myocyte cell apoptosis in ischemia/
reperfusion injury. Circulation 104(3):253–256
127. Scarabelli TM, Stephanou A, Pasini E, Comini L, Raddino R,
Knight RA, Latchman DS (2002) Different signaling path-
ways induce apoptosis in endothelial cells and cardiac myo-
cytes during ischemia/reperfusion injury. Circ Res 90(6):745–
748
128. Scarpa A, Graziotti P (1973) Mechanisms for intracellular
calcium regulation in heart. I. Stopped-flow measurements of
Ca2+ uptake by cardiac mitochondria. J Gen Physiol 62
(6):756–772
129. Schrauwen P, Hoeks J, Schaart G, Kornips E, Binas B, Van De
Vusse GJ, Van Bilsen M, Luiken JJ, Coort SL, Glatz JF, Saris
WH, Hesselink MK (2003) Uncoupling protein 3 as a mitochon-
drial fatty acid anion exporter. FASEB J 17(15):2272–2274.
doi:10.1096/fj.03-0515fje
130. Shenouda SM, Widlansky ME, Chen K, Xu G, Holbrook M,
Tabit CE, Hamburg NM, Frame AA, Caiano TL, Kluge MA,
Duess MA, Levit A, Kim B, Hartman ML, Joseph L, Shirihai
OS, Vita JA (2011) Altered mitochondrial dynamics contributes
to endothelial dysfunction in diabetes mellitus. Circulation 124
(4):444–453. doi:10.1161/circulationaha.110.014506
131. Sourij H, Saely CH, Schmid F, Zweiker R, Marte T, Wascher TC,
Drexel H (2010) Post-challenge hyperglycaemia is strongly asso-
ciated with future macrovascular events and total mortality in
angiographied coronary patients. Eur Heart J 31(13):1583–
1590. doi:ehq099
132. Spitaler MM, Graier WF (2002) Vascular targets of redox signalling
in diabetes mellitus. Diabetologia 45(4):476–494. doi:10.1007/
s00125-002-0782-0
133. Stocker R, Keaney JF Jr (2004) Role of oxidative modifications
in atherosclerosis. Physiol Rev 84(4):1381–1478. doi:10.1152/
physrev.00047.2003
134. Tamareille S, Mignen O, Capiod T, Rucker-Martin C, Feuvray D
(2006) High glucose-induced apoptosis through store-operated
calcium entry and calcineurin in human umbilical vein endothe-
lial cells. Cell Calcium 39(1):47–55. doi:S0143-4160(05)00181-8
135. Tanaka K, Sugiura Y, Ichishita R, Mihara K, Oka T (2011) KLP6:
a newly identified kinesin that regulates the morphology and
transport of mitochondria in neuronal cells. J Cell Sci 124(Pt
14):2457–2465. doi:jcs.086470
136. Thyagarajan B, Malli R, Schmidt K, Graier WF, Groschner K
(2002) Nitric oxide inhibits capacitative Ca2+ entry by suppres-
sion of mitochondrial Ca2+ handling. Br J Pharmacol 137(6):821–
830. doi:10.1038/sj.bjp.0704949
137. Trenker M, Fertschai I, Malli R, Graier WF (2008) UCP2/3—
likely to be fundamental for mitochondrial Ca2+ uniport. Nat Cell
Biol 10(11):1237–1240
138. Trenker M, Malli R, Fertschai I, Levak-Frank S, Graier WF
(2007) Uncoupling proteins 2 and 3 are fundamental for mito-
chondrial Ca2+ uniport. Nat Cell Biol 9(4):445–452. doi:ncb1556
139. Tsukimori K, Fukushima K, Tsushima A, Nakano H (2005)
Generation of reactive oxygen species by neutrophils and endo-
thelial cell injury in normal and preeclamptic pregnancies. Hyper-
tension 46(4):696–700. doi:01.HYP.0000184197.11226.71
140. Ungvari Z, Bagi Z, Feher A, Recchia FA, Sonntag WE, Pearson
K, de Cabo R, Csiszar A (2010) Resveratrol confers endothelial
protection via activation of the antioxidant transcription factor
Nrf2. Am J Physiol 299(1):H18–H24. doi:ajpheart.00260.2010
141. Ungvari Z, Labinskyy N, Mukhopadhyay P, Pinto JT, Bagi Z,
Ballabh P, Zhang C, Pacher P, Csiszar A (2009) Resveratrol
attenuates mitochondrial oxidative stress in coronary arterial endo-
thelial cells. Am J Physiol 297(5):H1876–H1881. doi:00375.2009
142. Vaux DL (2011) Apoptogenic factors released from mitochondria.
Biochim Biophys Acta 1813(4):546–550. doi:S0167-4889(10)
00217-X
143. Victor VM, Nunez C, D’Ocon P, Taylor CT, Esplugues JV,
Moncada S (2009) Regulation of oxygen distribution in tissues
by endothelial nitric oxide. Circ Res 104(10):1178–1183. doi:
CIRCRESAHA.109.197228
144. Vindis C, Elbaz M, Escargueil-Blanc I, Auge N, Heniquez A,
Thiers JC, Negre-Salvayre A, Salvayre R (2005) Two distinct
calcium-dependent mitochondrial pathways are involved in oxi-
dized LDL-induced apoptosis. Arterioscler Thromb Vasc Biol 25
(3):639–645. doi:01.ATV.0000154359.60886.33
145. Waldeck-Weiermair M, Duan X, Naghdi S, Khan MJ, Trenker M,
Malli R, Graier WF (2010) Uncoupling protein 3 adjusts mito-
chondrial Ca2+ uptake to high and low Ca2+ signals. Cell Calcium
48(5):288–301. doi:S0143-4160(10)00152-1
146. Waldeck-Weiermair M, Jean-Quartier C, Rost R, Khan MJ, Vishnu
N, BondarenkoAI, Imamura H,Malli R, GraierWF (2011) Leucine
zipper EF hand-containing transmembrane protein 1 (Letm1) and
uncoupling proteins 2 and 3 (UCP2/3) contribute to two distinct
mitochondrial Ca2+ uptake pathways. J Biol Chem 286(32):28444–
28455. doi:M111.244517
Pflugers Arch - Eur J Physiol (2012) 464:63–76 75
147. Waldeck-Weiermair M, Malli R, Naghdi S, Trenker M, Kahn MJ,
Graier WF (2010) The contribution of UCP2 and UCP3 to mitochon-
drial Ca2+ uptake is differentially determined by the source of supplied
Ca2+. Cell Calcium 47(5):433–440. doi:S0143-4160(10)00048-5
148. Walter DH, Haendeler J, Galle J, Zeiher AM, Dimmeler S (1998)
Cyclosporin A inhibits apoptosis of human endothelial cells by
preventing release of cytochrome C from mitochondria. Circulation
98(12):1153–1157
149. Wang J, Alexanian A, Ying R, Kizhakekuttu TJ, Dharmashankar
K, Vasquez-Vivar J, Gutterman DD, Widlansky ME (2011) Acute
exposure to low glucose rapidly induces endothelial dysfunction
and mitochondrial oxidative stress: role for AMP kinase. Arterios-
cler Thromb Vasc Biol (in press). doi: ATVBAHA.111.227389
150. Wascher TC, Toplak H, Krejs GJ, Simecek S, Kukovetz WR, Graier
WF (1994) Intracellular mechanisms involved in D-glucose-mediated
amplification of agonist-induced Ca2+ response and EDRF formation
in vascular endothelial cells. Diabetes 43(8):984–991
151. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura
T, Nyengaard JR, van den Enden M, Kilo C, Tilton RG (1993)
Hyperglycemic pseudohypoxia and diabetic complications. Diabetes
42(6):801–813
152. Wood PG, Gillespie JI (1998) Evidence for mitochondrial Ca2+-
induced Ca2+ release in permeabilised endothelial cells. Biochem
Biophys Res Commun 246(2):543–548. doi:S0006-291X(98)
98661-2
153. Xu XP, Pollock JS, Tanner MA, Myers PR (1995) Hypoxia
activates nitric oxide synthase and stimulates nitric oxide produc-
tion in porcine coronary resistance arteriolar endothelial cells.
Cardiovasc Res 30(6):841–847. doi:0008636395001174
154. Yaffe MP (1999) The machinery of mitochondrial inheritance and
behavior. Science 283(5407):1493–1497
155. Yakes FM, Van Houten B (1997) Mitochondrial DNA damage is
more extensive and persists longer than nuclear DNA damage in
human cells following oxidative stress. Proc Natl Acad Sci USA 94
(2):514–519
156. Yu T, Robotham JL, Yoon Y (2006) Increased production of
reactive oxygen species in hyperglycemic conditions requires
dynamic change of mitochondrial morphology. Proc Natl Acad
Sci USA 103(8):2653–2658. doi:0511154103
157. Zamzami N, Marchetti P, Castedo M, Hirsch T, Susin SA, Masse
B, Kroemer G (1996) Inhibitors of permeability transition inter-
fere with the disruption of the mitochondrial transmembrane
potential during apoptosis. FEBS Lett 384(1):53–57. doi:0014-
5793(96)00280-3
158. Zeng L, Zampetaki A, Margariti A, Pepe AE, Alam S, Martin D,
Xiao Q, Wang W, Jin ZG, Cockerill G, Mori K, Li YS, Hu Y,
Chien S, Xu Q (2009) Sustained activation of XBP1 splicing
leads to endothelial apoptosis and atherosclerosis development
in response to disturbed flow. Proc Natl Acad Sci USA 106
(20):8326–8331. doi:0903197106
159. Zhang L, Zhou G, Song W, Tan X, Guo Y, Zhou B, Jing H, Zhao S,
Chen L (2012) Pterostilbene protects vascular endothelial cells
against oxidized low-density lipoprotein-induced apoptosis in vitro
and in vivo. Apoptosis 17(1):25–36. doi:10.1007/s10495-011-0653-6
160. Zmijewski JW, Moellering DR, Le Goffe C, Landar A,
Ramachandran A, Darley-Usmar VM (2005) Oxidized LDL
induces mitochondrially associated reactive oxygen/nitrogen
species formation in endothelial cells. Am J Physiol 289(2):
H852–H861. doi:00015.2005
161. Zweier JL, Talukder MA (2006) The role of oxidants and free
radicals in reperfusion injury. Cardiovasc Res 70(2):181–190.
doi:S0008-6363(06)00086-1
76 Pflugers Arch - Eur J Physiol (2012) 464:63–76
